Literature DB >> 14594861

Pathophysiological significance of peroxidative stress, neuronal damage, and membrane permeability in acute mountain sickness.

Damian M Bailey1, Gian-Reto Kleger, Manfred Holzgraefe, Peter E Ballmer, Peter Bärtsch.   

Abstract

Free radical-mediated changes in vascular permeability and subsequent inflammatory response may be a contributory pathogenetic cofactor responsible for the development of neurological sequelae associated with acute mountain sickness (AMS). To investigate this, 49 subjects were examined at sea level and serially after rapid ascent to 4,559 m. Although the venous concentration of total creatine phosphokinase activity was measured in all subjects, a complementary examination of lipid peroxidation (F(2)-isoprostanes), inflammatory (TNF-alpha, IL-1beta, IL-2, IL-6, IL-8, C-reactive protein), and cerebrovascular tissue damage (neuron-specific enolase) biomarkers was confined to a subcohort of 24 subjects. A selective increase (P < 0.05) in total creatine phosphokinase was observed in subjects diagnosed with AMS at high altitude (n = 25) compared with apparently healthy controls (n = 24). However, despite a marked increase in IL-6 and C-reactive protein attributable primarily to subjects developing high-altitude pulmonary edema, subcohort analyses demonstrated no selective differences in F(2)-isoprostanes, neuron-specific enolase, or remaining proinflammatory cytokines due to AMS (n = 14). The present findings are the first to demonstrate that free radical-mediated neuronal damage of sufficient degree to be detected in the peripheral circulation does not occur and is, therefore, unlikely to be an important, initiating event that is critical for the development of AMS. The pathophysiological significance of increased sarcolemmal membrane permeability and inflammatory response, either as a cause or epiphenomenon of AMS and/or high-altitude pulmonary edema, remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14594861     DOI: 10.1152/japplphysiol.00704.2003

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  16 in total

1.  Acute mountain sickness, inflammation, and permeability: new insights from a blood biomarker study.

Authors:  Colleen Glyde Julian; Andrew W Subudhi; Megan J Wilson; Andrew C Dimmen; Travis Pecha; Robert C Roach
Journal:  J Appl Physiol (1985)       Date:  2011-06-02

2.  Lung oxidative stress as related to exercise and altitude. Lipid peroxidation evidence in exhaled breath condensate: a possible predictor of acute mountain sickness.

Authors:  O F Araneda; C García; N Lagos; G Quiroga; J Cajigal; M P Salazar; C Behn
Journal:  Eur J Appl Physiol       Date:  2005-09-30       Impact factor: 3.078

Review 3.  Tumor necrosis factor and stroke: role of the blood-brain barrier.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Prog Neurobiol       Date:  2007-08-06       Impact factor: 11.685

4.  Nrf2 activation: a potential strategy for the prevention of acute mountain sickness.

Authors:  Christina Lisk; Joe McCord; Swapan Bose; Tim Sullivan; Zoe Loomis; Eva Nozik-Grayck; Thies Schroeder; Karyn Hamilton; David C Irwin
Journal:  Free Radic Biol Med       Date:  2013-05-27       Impact factor: 7.376

Review 5.  High-altitude physiology and pathophysiology: implications and relevance for intensive care medicine.

Authors:  Michael Grocott; Hugh Montgomery; Andre Vercueil
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

6.  Remote ischemic preconditioning delays the onset of acute mountain sickness in normobaric hypoxia.

Authors:  Marc M Berger; Hannah Köhne; Lorenz Hotz; Moritz Hammer; Kai Schommer; Peter Bärtsch; Heimo Mairbäurl
Journal:  Physiol Rep       Date:  2015-03

Review 7.  Lung oxidative damage by hypoxia.

Authors:  O F Araneda; M Tuesta
Journal:  Oxid Med Cell Longev       Date:  2012-08-26       Impact factor: 6.543

8.  Effects of acute exposure to moderate altitude on vascular function, metabolism and systemic inflammation.

Authors:  Anne-Christin Stöwhas; Tsogyal D Latshang; Christian M Lo Cascio; Sina Lautwein; Katrin Stadelmann; Noemi Tesler; Lisa Ayers; Kaspar Berneis; Philipp A Gerber; Reto Huber; Peter Achermann; Konrad E Bloch; Malcolm Kohler
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

9.  Neutrophil gelatinase-associated lipocalin: its response to hypoxia and association with acute mountain sickness.

Authors:  Adrian Mellor; Christopher Boos; Mike Stacey; Tim Hooper; Chris Smith; Joe Begley; Jo Yarker; Rick Piper; John O'Hara; Rod King; Steve Turner; David R Woods
Journal:  Dis Markers       Date:  2013-10-20       Impact factor: 3.434

10.  Evidence for cerebral edema, cerebral perfusion, and intracranial pressure elevations in acute mountain sickness.

Authors:  Dana M DiPasquale; Stephen R Muza; Andrea M Gunn; Zhi Li; Quan Zhang; N Stuart Harris; Gary E Strangman
Journal:  Brain Behav       Date:  2016-02-05       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.